Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Confluent raises funds for adhesion barrier trial:

This article was originally published in Clinica

Executive Summary

Biosurgery company Confluent Surgical, which develops products based on in situ polymerised hydrogel polymers and associated delivery systems, has raised $20m in a venture funding round. The Waltham, Massachusetts-based company's products are designed for post-surgical adhesion prevention and surgical sealing applications. The company will use the funds to support the completion of US trials into the SprayGel adhesion barrier, as well as extending the company's portfolio into surgical sealants for neuro, spine and cardiovascular surgery.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT067099

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel